Please ensure Javascript is enabled for purposes of website accessibility

Moguls Match Up Over News Corp.

By Dave Marino-Nachison – Updated Nov 16, 2016 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rupert Murdoch and John Malone may be preparing for a fight over the media giant.

Shares of international media giant News Corp. (NYSE:NWS) fell nearly 4% yesterday following the company's announcement that it adopted a "shareholder rights plan," better known as a "poison pill" -- and the connotations of the latter term should explain to novice investors why something known by the former might not be welcomed by investors.

Among other provisions, the "poison pill" -- put in place, in the company's words, to "protect the best interests of all shareholders" -- gives News Corp. investors the right to buy shares of the company at a discount should an outside organization obtain (or attempt to obtain through a tender offer) at least 15% of the company. Generally speaking, investors tend not to like these plans because they're seen as a takeover defense that could hurt liquidity.

As fellow Fool Bill Mann explains it: "Here's the deal with 'poison pills' -- they should more accurately be known as 'management rights plans,' since what they do is actually limit shareholders' ability to choose whether to go along with a hostile takeover on its merits. Most successful mergers usually result in gains in stock price of the acquired company. In many cases, the driving rationale for the acquirer to attempt to take over the company is poor management at the target company."

It isn't always clear what event triggers a company's decision to adopt a "poison pill." However, in this case, it's crystal clear.

Last week Liberty Media (NYSE:L) entered into a transaction with a division of Merrill Lynch (NYSE:MER) that, upon completion, would boost its share in News Corp. from 9% to 17%.

News Corp, essentially a family operation with Rupert Murdoch's kin owning about 30% of the company, clearly doesn't like the looks of Liberty's interloping: The "poison pill" allows the transaction but would be triggered should Liberty try to buy a bigger stake in News Corp.

What will happen next should be interesting: A CBS MarketWatch report indicates (unsurprisingly, given the larger-than-life status of moguls Murdoch and Liberty's John Malone) that Liberty dealt with Merrill without consultation with News Corp. That's not exactly polite and certainly suggests that Malone has designs on the company's post-Murdoch future -- if not something more immediate.

News Corp controls some big names in publishing and broadcasting, including British Sky Broadcasting (NYSE:BSY), Fox Entertainment (NYSE:FOX), and The New York Post tabloid newspaper.

Fool contributor Dave Marino-Nachison doesn't own any of the companies in this story.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Loews Corporation Stock Quote
Loews Corporation
L
$51.00 (-1.58%) $0.82
Twenty-First Century Fox, Inc. Stock Quote
Twenty-First Century Fox, Inc.
FOX

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.